» Articles » PMID: 33536900

A Review on Recent Advances in Aloperine Research: Pharmacological Activities and Underlying Biological Mechanisms

Overview
Journal Front Pharmacol
Date 2021 Feb 4
PMID 33536900
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Aloperine, a quinolizidine-type alkaloid, was first isolated from the seeds and leaves of herbal plant, . Empirically, . is appreciated for its anti-dysentry effect, a property that is commonly observed in other phytomedicines. Following the rationale of reductionism, subsequent biochemical analyses attribute such anti-dysentry effect to the bactericidal activity of aloperine. From then on, the multiple roles of aloperine are gradually revealed. Accumulating evidence suggests that aloperine possesses multiple pharmacological activities and holds a promising potential in clinical conditions including skin hyper-sensitivity, tumor and inflammatory disorders etc.; however, the current knowledge on aloperine is interspersed and needs to be summarized. To facilitate further investigation, herein, we conclude the key pharmacological functions of aloperine, and most importantly, the underlying cellular and molecular mechanisms are clarified in detail to explain the functional mode of aloperine.

Citing Articles

Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial Hypertension.

Liu H, Liu S, Ma P, Ma L, Liu Y, Zhao F Int J Nanomedicine. 2025; 20:871-886.

PMID: 39867311 PMC: 11761852. DOI: 10.2147/IJN.S489133.


Aloperine Ameliorates Acetaminophen-Induced Acute Liver Injury through HMGB1/TLR4/NF-B and NLRP3/Inflammasome Pathway.

Chen H, Wang S, Chen Q, Yu W, Nie H, Liu L Mediators Inflamm. 2024; 2024:3938136.

PMID: 39381066 PMC: 11461077. DOI: 10.1155/2024/3938136.


A review on the pharmacology, pharmacokinetics and toxicity of sophocarpine.

Wei S, Xiao J, Ju F, Liu J, Hu Z Front Pharmacol. 2024; 15:1353234.

PMID: 38746009 PMC: 11092382. DOI: 10.3389/fphar.2024.1353234.


Acute lung injury: a view from the perspective of necroptosis.

Dong J, Liu W, Liu W, Wen Y, Liu Q, Wang H Inflamm Res. 2024; 73(6):997-1018.

PMID: 38615296 DOI: 10.1007/s00011-024-01879-4.


Inhibitory effect of aloperine on transient outward potassium currents in rat cardiac myocytes.

Dong X, Li M Front Pharmacol. 2024; 15:1372973.

PMID: 38606176 PMC: 11007096. DOI: 10.3389/fphar.2024.1372973.


References
1.
Yamauchi S, Omi Y . Synthesis of an optically pure synthetic intermediate of aloperine from a yeast-reductive product. Biosci Biotechnol Biochem. 2005; 69(8):1589-94. DOI: 10.1271/bbb.69.1589. View

2.
Harvey A, Montezano A, Lopes R, Rios F, Touyz R . Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications. Can J Cardiol. 2016; 32(5):659-68. PMC: 4906153. DOI: 10.1016/j.cjca.2016.02.070. View

3.
Dang Z, Xie H, Zhu L, Zhang Q, Li Z, Huang L . Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors. ACS Med Chem Lett. 2017; 8(11):1199-1203. PMC: 5683702. DOI: 10.1021/acsmedchemlett.7b00376. View

4.
Xu Q, Bauer R, Hendry B, Fan T, Zhao Z, Duez P . The quest for modernisation of traditional Chinese medicine. BMC Complement Altern Med. 2013; 13:132. PMC: 3689083. DOI: 10.1186/1472-6882-13-132. View

5.
Zhao D, Liu J, Wang M, Zhang X, Zhou M . Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2018; 16(4):203-212. DOI: 10.1038/s41569-018-0119-4. View